Cardiac amyloidosis other diagnostic studies
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]
Overview
Overview
Reduced heart rate variability due to autonomic dysfunction can be observed on Holter monitoring. This lack of variability in the heart rate has been shown to be a more consistent predictive parameter of short-term mortality in patients with AL type amyloidosis with cardiac involvement as compared to those with AA type amyloidosis.
Other Diagnostic Studies
Other Diagnostic Studies
Holter Monitoring
- Reduced heart rate variability due to autonomic dysfunction can be observed on Holter monitoring.
- Reduced heart rate variability is a predictor of 1-year mortality in cardiac amyloidosis patients.[1]
- This lack of variability in the heart rate has been shown to be a more consistent predictive parameter of short-term mortality in patients with AL type amyloidosis with cardiac involvement as compared to those with AA type amyloidosis.
References
References
- ↑ Reyners AK, Hazenberg BP, Reitsma WD, Smit AJ (2002). “Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis”. European Heart Journal. 23 (2): 157–61. doi:10.1053/euhj.2001.2972. PMID 11785998. Unknown parameter
|month=ignored (help)
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH